ArticleBMC microbiology2026
Whole-genome analysis and fermentation-metabolite profiling of a cellulolytic Arthrobacter sp. FMD isolated from forest musk-deer faeces.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Most studies on the intestinal microbiota of the forest musk deer (Moschus berezovskii) are based on community-level sequencing, and functional characterisation of individual strains is rare. Here we isolated strain FMD from deer faeces by selecting on CMC-Na as the sole carbon source; it utilises xylose, trehalose and fructose and is positive for urease and the methyl-red test. Whole-genome sequencing yielded a 4.05 Mb chromosome (GC 64.1%, four contigs, 3 726 CDS), and phylogenomic analyses (20 core genes, ANI and SNP tree) placed the isolate in the genus Arthrobacter; the strain was designated Arthrobacter sp. FMD. The genome encodes abundant catabolic functions, including 128 CAZymes, 27 COG and 34 KEGG genes for carbohydrate metabolism, and 54 COG and 45 KEGG genes for amino-acid metabolism, while VFDB and PHI searches indicate low pathogenic potential. Fermentation of wheat bran with Arthrobacter sp. FMD increased carboxylic acids from 21.8% to 33.4% and decreased fatty acyls from 24.2% to 10.8%. Isoquercitrin, 2-oxindole-3-acetic acid and 5-hydroxyindole-3-acetic acid were the most up-regulated metabolites, whereas Leu-Trp, 6′-O-feruloyl catalpol and Cnidioside A were the most down-regulated. Isoleucylvaline, γ-glutamyl-methionine and N²-acetylornithine showed the highest increases among amino-acid derivatives, and isovaleric, valeric, 2-hydroxy-2-methylbutyric and 2-hydroxy-3-methylbutyric acids were the predominant organic-acid products. These findings suggest that Arthrobacter sp. FMD deploys a coordinated set of hydrolases and downstream catabolic enzymes that degrade lignocellulose-derived substrates, reduce anti-nutritional factors and enrich organic acids, nucleosides and flavonoids, highlighting its potential to improve feed utilisation and gut health in the forest musk deer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.